Journal:
:jundishapur journal of natural pharmaceutical products
0
ali asghar hemmeti department of pharmacology and toxicology, school of pharmacy, ahvaz jundishapur university of medical sciences, ahvaz, ir iran; physiology research center, ahvaz jundishapur university of medical sciences, ahvaz, ir iran
mohammad rahim zerafatfard department of pharmacology and toxicology, school of pharmacy, ahvaz jundishapur university of medical sciences, ahvaz, ir iran
mehdi goudarzi department of pharmacology and toxicology, school of pharmacy, ahvaz jundishapur university of medical sciences, ahvaz, ir iran
mohammad javad khodayar department of pharmacology and toxicology, school of pharmacy, ahvaz jundishapur university of medical sciences, ahvaz, ir iran; toxicology research center, ahvaz jundishapur university of medical sciences, ahvaz, ir iran; department of pharmacology and toxicology, school of pharmacy, ahvaz jundishapur university of medical sciences, ahvaz, ir iran. tel: +98-6133738378
anahita rezaie department of pathobiology, faculty of veterinary medicine, shahid chamran university of ahvaz, ahvaz, iran
mohammad reza rashidi nooshabadi department of pharmacology and toxicology, school of pharmacy, ahvaz jundishapur university of medical sciences, ahvaz, ir iran
conclusions atorvastatin may play a protective role in pulmonary fibrosis, with its effects mediated via the station’s antioxidant and anti-inflammatory properties. atorvastatin may be a potential agent for the treatment of lung injury and fibrosis. background pulmonary fibrosis is an idiopathic and chronic inflammatory interstitial lung disease, with a negligible response to available medical t...
